Analog Devices Inc
Change company Symbol lookup
Select an option...
ADI Analog Devices Inc
BAC Bank of America Corp
CLOV Clover Health Investments Corp
HRL Hormel Foods Corp
DD Dupont De Nemours Inc
PSRU Valiant Eagle Inc
CRM Salesforce.Com Inc
VLYPP Valley National Bancorp
FEMKX Fidelity® Emerging Markets Fund
XPEV Xpeng Inc
Go

Information Technology : Semiconductors & Semiconductor Equipment | Large Cap Blend
Company profile

Analog Devices, Inc. (Analog Devices) designs, manufactures and markets a portfolio of solutions that leverage high-performance analog, mixed-signal and digital signal processing technology, including integrated circuits (ICs), algorithms, software and subsystems. Its products include Analog Products, Converters, Amplifiers/Radio Frequency, Other Analog, Power Management and Reference, and Digital Signal Processing Products. The Company is a supplier of data converter products. The Company is a supplier of high-performance amplifiers. Its analog product line also includes products of high performance radio frequency (RF) ICs. The Company's DSPs are used for high-speed numeric calculations. The Company offers its products for applications in various end markets, such as industrial, automotive, consumer and communications. The Company operates in the United States, Rest of North/South America, Europe, Japan and China.

Postmarket

Last Trade
Delayed
$156.38
2.09 (1.35%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$154.29
Day's Change
-4.30 (-2.71%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
159.41
Day's Low
154.03
Volume
(Below Average)
Volume:
3,016,479

10-day average volume:
3,526,468
3,016,479

SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of Important December 15 Deadline in Securities Class Action Lawsuit against Evolus Inc.; Encourages Investors with Losses in Excess of $50,000 to Contact the Firm

11:58 am ET December 9, 2020 (Globe Newswire) Print

Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, has filed a federal securities class action in the United States District Court for the Southern District of New York on behalf of its client and all similarly situated investors who purchased or otherwise acquired common stock of Evolus Inc. ("Evolus" or the Company") (NYSE: EOLS) from February 1, 2019 to July 6, 2020, inclusive (the "Class Period"). The class action alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), 15 U.S.C. §§ 78j(b) and 78t(a) and Rule 10b-5 promulgated thereunder by the SEC, 17 C.F.R. § 240.10b-5. The class action is titled In re Evolus Securities Litigation, No. 1:20-cv-08647 (S.D.N.Y.).

Evolus is a California based medical aesthetics company. The Company and its South Korean partner, Daewoong Pharmaceutical Co. ("Daewoong") developed Jeuveau, a competitor to Allergan's Botox. Jeuveau has recently become a strong, more affordable competitor of Botox.

On July 6, 2020, Judge David Shaw of the International Trade Commission issued a preliminary ruling in a trade secrets action accusing Evolus and Daewoong of having developed Jeuveau, using trade secrets stolen from Allergan's partner company, Medytox. In a non-binding decision, the judge sided with Allergan and Medytox and recommended a 10-year ban on Jeuveau imports to the United States.

On this news, shares of Evolus fell sharply, from $5.55 to close at $3.25, on July 7, 2020, representing a loss of more than 41%.

If you wish to serve as a lead plaintiff and if you have suffered a net loss of more than $50,000 from investment in Evolus' common stock from February 1, 2019 to July 6, 2020, you must move the Court no later than December 15, 2020. You may obtain additional information about this lawsuit and your ability to become a Lead Plaintiff, by contacting Christian Levis at clevis@lowey.com or by calling 914-733-7220 or Andrea Farah at afarah@lowey.com or by calling 914-733-7256.

About Lowey Dannenberg

Since its inception in 1967, Lowey has specialized in the prosecution of complex civil class action lawsuits and has grown into one of the most successful shareholder litigation firms in the field. Its investor litigation group has recovered billions of dollars in the aggregate and has achieved landmark, long-term corporate governance changes at public companies. Over decades of zealous advocacy, Lowey has developed a profound knowledge of securities and antitrust class action litigation.

Contact

Lowey Dannenberg P.C.

44 South Broadway, Suite 1100

White Plains, NY 10601

Tel: (914) 733-7256

Email: investigations@lowey.com

https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png

https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.